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Stem cellsArticular cartilage lesions have a limited ability to heal by themselves. Yet, golden standard treatments
for cartilage repair such as drilling, microfracture and mosaicplasty provide further damage and an unsta-
ble solution that degenerates into fibrocartilage in time. Articular cartilage presents a number of gradi-
ents in cell number and size along with structural gradients in extra cellular matrix (ECM)
composition. Therefore, creating scaffolds that display a structural gradient can be an appealing strategy
for cartilage tissue regeneration treatments. In the present study, a scaffold with an in-built discrete gra-
dient in pore size was produced by additive manufacturing. Human mesenchymal stromal cells (hMSCs)
were seeded within the gradient scaffolds and their proliferation, differentiation and ECM deposition was
evaluated with respect to 2 non-gradient scaffolds. Glycosaminoglycan (GAG) deposition was signifi-
cantly higher in gradient scaffolds and non-gradient scaffolds with the smallest pore size compared to
non-gradient scaffolds with the largest pore size. A gradual increase of chondrogenic markers was
observed within the gradient structures with decreasing pore size, which was also accompanied by an
increasingly compact ECM formation. Therefore, scaffolds displaying a structural gradient in pore size
seem to be a promising strategy to aid in the process of hMSC chondrogenic differentiation and could
be considered for improved cartilage tissue regeneration applications.
Statement of Significance
We present the development of a novel hierarchical scaffold obtained by additive manufacturing.
Structural hierarchy is obtained by changing pore size within the pore network characterizing the fabri-
cated scaffolds and proves to be a functional element in the scaffold to influence adult stem cell differ-
entiation in the chondrogenic lineage. Specifically, in regions of the scaffolds presenting smaller pores
an increasing differentiation of stem cells toward the chondrogenic differentiation is displayed. Taking
inspiration from the zonal organization of articular cartilage tissue, pore size gradients could, therefore,
be considered as a new and important element in designing 3D scaffolds for regenerative medicine appli-
cations, in particular for all those tissues where gradient physical properties are present.
 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.1. Introduction surface to the underlying subchondral bone [1]. Cartilage can beCartilage is the tissue located at the extremity of long bones and
is responsible for the transmission of forces from the articularaffected by progressive degenerative diseases such as osteoarthri-
tis, which involves the osteochondral or chondral tissue depending
on the depth of the injury. This process can be triggered by a severe
trauma, repetitive minor injuries or aging process [2]. Currently, an
optimum treatment for such type of lesions is still under debate.
Articular cartilage lesions generally do not heal, or heal only par-
tially under certain biological conditions [3]. Among the available
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aged site such as drilling, microfracture or spongialization [4,5].
Bleeding from the subchondral bone would then ensure the deliv-
ery of mononuclear cells and growth factors contained in the bone
marrow responsible for the temporary healing of the damaged site.
Other proposed techniques consist in the transplantation of autol-
ogous cells [6,7], perichondrial/periosteal grafts [8], and autolo-
gous or allogenic osteochondral transplantation [9,10]. Since all
these proposed solutions present several drawbacks related to
morbidity, risks of infections, lack of available tissues, and re-
degeneration of the repaired tissue, the use of biomaterial-based
strategies to promote and direct tissue growth emerged in the past
decades. Several techniques have been proposed in literature to
produce scaffolds, such as freeze drying [11], salt leaching
[12,13], solvent casting [13] and gas foaming [14]. The success of
a scaffold resides in some characteristic features such as total
porosity, pore size and interconnectivity, mechanical and
physico-chemical properties. The fore mentioned techniques lack
control of one or more of these characteristics. Additive manufac-
turing has been used to fabricate scaffolds due to its ability of over-
coming these drawbacks and the possibility to fine tune scaffolds
characteristics such as pore shape and size. Additionally, a gradual
variation of the scaffolds characteristics can be achieved within the
same construct, allowing the design and production of scaffolds
displaying structural gradients [15,16].
Gradients are also present in the human body from the develop-
mental phase to adult life. Morphogen gradients are known to lead
to the formation of the osteochondral tissue [17]. At the tissue
interface, the gradual variation from one tissue to the other is
based on gradients. Skin and bone present a gradient structure in
the axial direction and the radial direction, respectively. Cartilage
is a tissue which displays an internal variation of properties such
as stiffness [18–20], extracellular matrix (ECM) composition
[2,18] and cell shape and number [21,22] along the axial direction
as well. In particular, articular cartilage displays a gradient in pro-
teoglycans, collagen type II, and water content. While proteoglycan
content increases from the calcified region to the surface plateau,
collagen type II and water content increases from the surface pla-
teau to the calcified zone [23]. Therefore, the use of gradient scaf-
folds could be a feasible solution for cartilage regeneration. In the
present study, scaffolds with a discrete gradient in pore size in the
axial direction were fabricated by additive manufacturing. The pro-
liferation, ECM deposition and differentiation of human bone mar-
row derived mesenchymal stromal cells (hMSCs) toward the
chondrogenic lineage were evaluated. Furthermore, we analyzed
the differentiation of hMSCs within the compartments of the gradi-
ent in order to correlate their differentiation to the size of the
pores. We hypothesized that a variation in pore size could indi-
rectly result into a local gradient in nutrient availability during cul-
ture. Correspondently, this may result in gradual hypoxic culture
conditions, which are known to facilitate chondrogenesis [24,25].
hMSCs have been chosen due to their potential to differentiate into
different skeletal lineages, among others [26,27]. Their presence in
the mononuclear cell fraction of the subchondral bone marrow fur-
ther guarantees a potentially straightforward clinical application,
as hMSCs are often thought to be responsible for cartilage repair
in current clinical surgical procedures such as microfracture.2. Materials & methods
2.1. Scaffolds preparation
Scaffolds were fabricated via 3D fiber deposition (Bioscaffolder,
SysENG, Germany). Scaffolds made of poly(ethylene oxide tereph-
thalate)/poly(butylene terephthalate) (PEOT/PBT) were produced.PEOT/PBT is a family of block co-polymers characterized by an
aPEOTbPBTc nomenclature, where a is the molecular weight of
the starting PEG block and b and c are the PEOT/PBT ratio. A
300PEOT55PBT45 composition was chosen due to its proven
potential for skeletal regeneration [28,29]. Briefly, the polymer
(300PEOT55PBT45, PolyVation, The Netherlands) was placed in a
stainless syringe and processed at 200 C. The molten polymer
was extruded through a cartridge unit, by the application of a
nitrogen flow with a pressure of 5 bar from a pressurized cap
and an extrusion screw rotation of 200 rpm.
During plotting, the needle diameter, layer thickness and speed
were kept constant at 200 lm, 150 lm and 180 mm/min, respec-
tively. The fiber spacing was kept constant to 500 lm and
1100 lm for non-gradient (NG) scaffolds and varied from 500 lm
to 1100 lm for gradient (G) scaffolds. The fiber spacing was chan-
ged every millimeter. The scaffolds were plotted in blocks of
20  20 mm and 4 mm in height. The tested samples were
4  4 mm cylinders punched out from the blocks.
2.2. Cell expansion and culture
hMSCs (male, age 22) were retrieved from the Institute of
Regenerative Medicine (Temple, Texas). Briefly, a bone marrow
aspirate was drawn and mononuclear cells were separated using
density centrifugation. The cells were plated to obtain adherent
hMSCs, which were harvested when cells reached 60–80% conflu-
ence. These were considered passage 0 (P0) cells. These P0 cells
were expanded, harvested and frozen at passage 1 (P1) for distri-
bution. Cells were grown in MSC proliferation medium, which con-
tains minimal essential medium (a-MEM, Life Technologies,
Bleiswijk, the Netherlands) supplemented with 10% fetal bovine
serum (FBS, Lonza), 100 U/ml penicillin (Life Technologies, Bleiswijk,
the Netherlands), 10 lg/ml streptomycin (Life Technologies,
Bleiswijk, the Netherlands), 2 mM L-glutamin (Life Technologies,
Bleiswijk, the Netherlands), 0.2 mM L-ascorbic acid 2-phosphate
magnesium salt (ASAp, Sigma-Aldrich, Zwijndrecht, The Nether-
lands) and 1 ng/ml of basic fibroblast growth factor-2 (bFGF-2,
Fisher Scientific, Landsmeer, the Netherlands) at 37 C in a humid
atmosphere with 5% CO2. Cells were expanded up to approximately
80% confluency and either frozen for further use or seeded on the
scaffolds.
2.3. Cell seeding on scaffolds
After trypsinization with 0.25% trypsin (Life Technologies,
Bleiswijk, the Netherlands), cells (passage 2–4) were counted using
a Bückner chamber and re-suspended in proliferation medium at a
density of 500,000 cells in 40 lL. The day before seeding, scaffolds
were disinfected in 70% EtOH for 30 min under stirring, washed 3
times in phosphate buffered saline solution (PBS) (Lonza, Breda,
the Netherlands), and incubated overnight in proliferation medium
to allow protein adsorption on the scaffold’s fibers. After protein
adsorption, the 40 lL of cell suspension were placed on the scaffold
in a drop wise fashion to account for a cell seeding density of
500,000 cells/scaffold. The seeded scaffolds were placed for 4 h in
the incubator to allow cell adhesion before adding the cell culture
medium.
Cells were cultured on the G and NG scaffolds for 7 days in pro-
liferation medium. At day 7, the proliferation medium was chan-
ged and the cell-seeded scaffolds were cultured for another
28 days in basic medium presenting the same formulation as the
proliferation medium without bFGF, or chondrogenic medium
consisting of DMEM supplemented with 50 mg/mL ITS-premix
(Bexton Dickinson), 0.4 mM Proline (Sigma-Aldrich, Zwijndrecht,
The Netherlands), 50 mg/mL ascorbic acid (ASAp, Sigma-Aldrich,
Zwijndrecht, The Netherlands), 100 mg/mL sodium pyruvate
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(Life Technologies, Bleiswijk, the Netherlands), 10 lg/ml strepto-
mycin (Life Technologies, Bleiswijk, the Netherlands), 10 ng/mL
transforming growth factor b3 (TGF-b3) (Life Technologies,
Bleiswijk, the Netherlands) and 107 M dexamethasone (Sigma-
Aldrich, Zwijndrecht, The Netherlands). Scaffolds were flipped
every day so to exchange ‘‘bottom” and ‘‘top” side of the scaffolds
to take into account the possible effect of gravity on cell distribu-
tion, where the ‘‘top” side is considered as the one with the smaller
pore size in the gradient scaffolds.
2.4. Partition analysis
To see the differences within the hMSCs cultured in the differ-
ent area of the gradient scaffolds, after 14 and 28 days under differ-
entiation conditions, the constructs were collected, washed 3 times
with PBS and cut in 3 portions of 1 mm in height. The division of
the pore size formed with a fiber spacing of 900 lm with the pore
size formed with a fiber spacing of 1100 lm was not possible due
to the poor mechanical properties; therefore, the 2 pore size por-
tions were analyzed together. Biochemical studies and gene




The cell number per scaffold was calculated from the lg of DNA,
obtained by a Cyquant DNA assay kit (Life Technologies, Bleiswijk,
The Netherlands). Briefly, each scaffold was cut to improve lysis
efficiency and freeze-thawed 5 times. After the freeze-thawing
process, cells within the scaffolds were lysated by diluting the
20 lysis buffer provided with the kit using a saline buffer
(180 mM NaCl, 1 mM EDTA in distilled water). After 1 h of lysis,
samples were sonicated 2 times for 10 s using a Branson sonifier
250 (Emerson Industrial Automation, USA). DNA content was
quantified with a CyQuant kit (Life Technologies, Bleiswijk, the
Netherlands) according to manufacturer’s protocol and fluores-
cence was measured at 480 nm using a spectrophotometer LS50B
(Perkin Elmer, The Netherlands). DNA concentrations were calcu-
lated from a k DNA standard curve.
2.5.2. GAG amount
To evaluate the differentiation toward the chondrogenic lin-
eage, the GAG amount was quantified using 1,9-Dimethyl Methy-
lene Blue (DMMB) assay. Therefore, 25 lL of sample were placed
into a transparent flat bottom 96 well plate and 5 lL of 2.3 M NaCl
solution were added, then 150 lL of DMMB solution were added
and absorbance was read using a Multiscan Go (Fisher Scientific,
Landsmeer, the Netherlands) plate reader at a wavelength of
525 nm. GAG content was quantified with a chondroitin standard
curve and corrected for DNA content.
2.5.3. Western Blot Analysis
hMSCs passage 2–4 were cultured in normoxic (21% oxygen)
conditions on both petri dishes and 3D scaffolds, and in hypoxic
(2.5% oxygen) conditions on petri dishes only (positive control).
The cells were lysed in radio-immunoprecipitation assay (RIPA)
lysis buffer (sc-24948, SantaCruz Biotechnology). The protein con-
tent was determined using a Pierce BCA protein assay kit (#23227,
Thermo Scientific Pierce), with bovine serum albumin used as a
standard. Each sample was mixed with 4 Laemmli Sample Buffer
(#161-0737, BioRad) under denaturing conditions. 20 lg of protein
sample were loaded per lane and resolved on a 4–20% precast poly-
acrylamide gel (#456-8094, BioRad). Proteins were transferred to a
PVDF membrane for immunoblotting. After blocking 1 h at roomtemperature with 5% BSA in Tris-buffered saline containing 0.1%
Tween-20 (Santa Cruz Biotechnology), the membranes were incu-
bated overnight at 4 C with HIF-1a (28b) antibody (#sc-13515,
Santa Cruz Biotechnology), or HIF-2a antibody (#sc-46691, Santa
Cruz Biotechnology), diluted 1:250 in Tris-buffered saline contain-
ing 0.1% Tween-20). GAPDH antibody (#sc-365062, Santa Cruz
Biotechnologies) diluted 1:2500 was used as loading control for
normalization. Membranes were washed with Tris-buffered saline,
and incubated with horseradish peroxidase (HRP)-conjugated sec-
ondary antibodies (DAKO) diluted 1:2500 in Tris-buffered saline
containing 0.1% Tween-20 for 45 min at room temperature. After
washing, blots were developed using Clarity Western ECL Sub-
strate (#1705060, BioRad) and the HRP activity of the blots were
imaged using a BioRad Chemidoc Touch imager. Finally, blots were
semi-quantified using ImageJ.
2.6. SEM analysis and computed tomography analysis
G and NG scaffolds were analyzed by scanning electron micro-
scopy (SEM, Philips – XL 30 ESEM-FEG). Directly after plotting,
scaffolds were punched, cut in half, gold sputtered (Cressington
sputter coater 108 auto) and analyzed. SEM images were analyzed
using Image J software in order to measure the fiber diameter, fiber
spacing, and pore dimensions. Pore dimensions can be calculated
by subtracting the fiber dimension from the fiber spacing in the
x-y plane, while they are identical to the layer thickness in the z
direction [30]. Scaffolds cultured in basic and chondrogenic media
for 28 days were fixed using 10% formalin, dehydrated by an
increasing series of ethanol concentration (50–60–70–80–90–96–
100%) and cut in half. The final dehydration step was carried out
via immersion in Hexamethyldisilazane (Sigma-Aldrich, Zwijn-
drecht, The Netherlands) and overnight evaporation. Dry scaffolds
were mounted on SEM stubs, gold sputtered, and analyzed for tis-
sue formation. Directly after plotting, scaffolds were analyzed by
micro-computed tomography (lCT). The X-ray measurements
were performed using SkyScan 1172 (Bruker) with the following
working parameters of X-ray tube: 40 kV and 250 lA. For a
3.97 lm pixel size, 600 projections were taken with exposure time
of 100 ms and 5 integrations for each exposition. The projections
were reconstructed with the special software (NRecon, ver.
1.6.10.4, Bruker microCT) and then exported to CTAn (ver.
1.15.4.0+, Bruker microCT) for further 3D image analysis. Recon-
structed slices were processed, resulting in 3D binary images.
Object volume, available surface and fiber spacing were calculated
for the whole volume of analyzed scaffolds.
2.7. Gene expression analysis
For gene expression analysis, the scaffolds were taken from the
medium, washed twice with PBS, cut into small pieces, placed in an
Eppendorf containing 750 lL of TRIzol (Invitrogen) and stored at
80 C. In case of partition analysis, the gradient scaffolds were cut
in order to separate the gradient zones and the 3 samples were
located in the same vial prior the addition of TRIzol, in order to
ensure the collection of enough RNA. RNA isolation was performed
by using a Bioke RNA II nucleospin RNA isolation kit (Bioke, Leiden,
The Netherlands). 150 lL of CHCl3 were added and the vials were
vigorously mixed, followed by a centrifugation at 12,000g for
15 min at 4 C. The aqueous phase was transferred into a new tube
and an equal amount of 70% ethanol was added. The mixture was
transferred into a filter column from the kit and the extraction was
carried on following the manufacturer’s protocol. RNA concentra-
tion and purity was evaluated via an ND1000 spectrophotometer
(Nanodrop Technologies, USA); cDNA was synthetized using
iScriptTM (BIO-RAD, Veenendaal, The Netherlands) according to
the manufacturer’s protocol. Quantitative polymerase chain
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iQ SYBRGreen Supermix (BIO-RAD, Veenendaal, The Netherlands)
and the primers listed in Table 1. PCR reaction was carried out on a
MyiQ2 Two-Color Real-Time PCR Detection System (BIO-RAD,
Veenendaal, The Netherlands) under the following conditions:
the cDNA was denatured for 10 min at 95 C, followed by 45 cycles,
consisting of 15 s at 95 C, 15 s at 60 C and 15 s at 72 C. A melting
curve was generated from each reaction to test the presence of
primer dimers and unspecific products. The cycle threshold was
calculated by the Bio-Rad iQ5 optical system software, in which
the threshold was set in the lower log-linear region of the fluores-
cent signal. Ct values were normalized by the B2M housekeeping
gene and DCt ((average of Ct control)  Ct value). Results were
expressed as fold induction in mRNA expression normalized to
the gene expression of the gradient scaffolds cultured in basic
medium. In the partition analysis, the relative RNA expression
was normalized by the big pore region (900/1100) cultured under
chondrogenic conditions.
2.8. Statistical analysis
All the quantitative data are expressed as mean ± standard devi-
ation. Statistics were performed using IBM SPSS Statistics 20. A
two-way ANOVA with Tukey as post hoc test was used. Statistical
significance between the control groups and the experimental
groups is indicated with (⁄) which represents a p-value <0.05, (⁄⁄)




Four zones in the gradient scaffold can be distinguished
(Fig. 1a and d), where the fiber spacing changed from bottom to
top from 463 lm ± 17 lm, to 646 lm ± 9 lm, 836 lm ± 23 lm,
1023 lm ± 26 lm. The resulting pore size was 326 lm ± 17 lm
when the fiber spacing was set at 500 lm, 540 lm ± 11 lm when
the fiber spacing was set at 700 lm, 744 lm ± 16 lm and
968 lm ± 25 lm when the fiber spacing was set at 900 and
1100 lm respectively as analyzed from SEM. The fiber diameter
was measured as 155 ± 20 lm. The lCT analysis showed a pore
size of 237.67 lm ± 7.77 lm when the fiber spacing was set at
500 lm, 389.33 lm ± 4.93 lm with a fiber spacing of 700 lm,
509 lm ± 4.36 lm and 538.33 lm ± 50.64 lmwhen the fiber spac-
ing was at 900 lm and 1100 lm respectively (Table 2b). Control
scaffolds were plotted by keeping the fiber spacing constant at
500 lm and 1100 lm, which was measured as 458 lm ± 15 lm
and 939 lm ± 88 lm, respectively, by SEM (Fig. 1c, and d). By
increasing the fiber spacing, the volume of the pore in the different
zones correspondently increased by 50% from the smallest to the
largest pore size (Fig. 1f). In parallel, by increasing the pore size
the surface available decreased from 114.75 mm2 ± 11.34 mm2 in
the smaller pore area to 44.72 mm2 ± 14.16 mm2 in the largest
pore area (Table 2b). The porosity of the different gradient areas
increased from 55.1% ± 1.4% to 81.8% ± 0.8% (Fig. 1e). The porosityTable 1
List of primers used for the gene expression analysis of hMSCs differentiation toward
the chondrogenic lineage.




Collagen IIa CGTCCAGATGACCTTCCTACG TGAGCAGGGCCTTCTTGAGcalculated with the lCT showed that the porosity of G scaffolds
were close to the one of NG500 scaffolds, 69.52% ± 0.31% and
70.80% ± 0.06%. NG1100 scaffolds displayed a porosity of
78.88% ± 0.7% (Table 2a).
3.2. Cell seeding efficiency and cell number
The presence of the gradient as well as the different pore size of
the controls didn’t affect cell attachment at 8 h from seeding
(Fig. 2a). At 28 days of differentiation, scaffolds cultured in basic
conditions displayed a higher cell number compared to the ones
cultured under chondrogenic conditions (Fig. 2b). Even at this late
time point the porosity didn’t affected the cell number per struc-
ture, since there was no statistical difference among gradient and
non-gradient scaffolds.
3.3. Induction of chondrogenic markers
After 14 days under chondrogenic conditions 2 out of 3 markers
chosen to detect chondrogenesis were upregulated (Fig. 3a). The
early marker sox9 appeared highly upregulated with a 7-fold
induction for the gradient and a 6- and 8-fold induction for the
NG500 and NG1100, respectively. The late marker aggrecan was
even more upregulated with a 38-fold induction for the gradient,
and a 32- and 31-fold induction for NG500 and NG1100 respec-
tively. Collagen type II displayed an initial increase in its expres-
sion with an upregulation of 2–3 times fold. No major differences
could be detected among the gradient and non-gradient structures.
After 28 days under differentiation conditions the produced gly-
cosaminoglycan (GAG) displayed a trend in which the NG1100
scaffolds showed 13.08 ± 4.98 lg of GAG/DNA, which was signifi-
cantly lower than the amount of GAG deposited by NG500 scaf-
folds (26.2 ± 2.07 lg of GAG/DNA) as shown in Fig. 3b. G
scaffolds showed an amount of GAG/DNA of 21.39 ± 2.92, which
was significantly higher with respect to the amount produced in
NG1100 scaffolds.
3.4. ECM analysis
After 28 days, the constructs cultured in basic medium dis-
played cells adhering to the fibers with produced ECM bridging
the pores and connecting subsequent fibers (Fig. 4a–f). When cul-
tured under chondrogenic conditions, all the samples displayed the
presence of ECM closing most of the pores (Fig. 4g–l). Samples cul-
tured under chondrogenic conditions displayed a consistently
higher ECM.
As shown in Fig. 4(m–p) from the small pores to the big pores
throughout the entire pore network, the gradient scaffolds were
filled with ECM. The ECM organization seemed more compact in
the area with fiber spacing of 700 lm and 500 lm (Fig. 4n, o),
and became looser when moving to the bottom part of the scaf-
folds characterized by the higher fiber spacing (Fig. 4p). Higher
magnification showed in both G and NG scaffolds spread cell mor-
phology, yet with more ECM fibrillary bundles present in G
scaffolds (Supporting Information, Fig. S2).
3.5. hMSCs differentiation and ECM deposition in respect of the pore
size zone
3.5.1. Gene expression per gradient zone
As showed in Fig. 5, the expression of aggrecan, collagen type II
and sox9 genes were analyzed in each portion of the gradient scaf-
folds. The early marker Sox 9 presented a 5-fold induction in the
smallest pore region, significantly higher than in the biggest pore
region. The portion with the fiber spacing of 700 lm presented a
2-fold induction, similar to the largest pore region. Collagen type
Fig. 1. Micrograph of the gradient and control scaffolds. (a, b) lCT reconstruction and SEM pictures of the G scaffold cross section. Pore size is increasing with the fiber
spacing along the z axis (scale bar 2 mm), SEMmicrograph of the control scaffolds NG500 (c) and NG1100 (d) (scale bar 500 lm). Graph displaying the increase in porosity (e)
and pore volume (f) along the z axis in the gradient scaffold.
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spacing was set at 500 lm and a 3-fold increase with a fiber spac-
ing of 700 lm. Aggrecan displayed the highest differences between
the portions with a 21- and a 4-fold increase in the 500 lm and
700 lm zones, respectively.3.5.2. Cellularity and ECM within the gradient
After 28 days of culture, hMSCs number decreased with increas-
ing the pore size in chondrogenic medium (Fig. 6b), while there
was no difference in basic medium. GAG amount followed the
same trend (Fig. 6a). The portion with the smallest pore size was
filled with a GAG/DNA amount of 65.06 ± 7.85 lg, which decreased
to 19 ± 2.73 lg in the further porosity zone and to 7.27 ± 2.44 in
the largest pore zone (Fig. 6a). A similar trend was seen under basic
conditions where the 900/1100 lm portion showed a significantly
lower amount of GAG/DNAwith respect to the 700 lm and 500 lm
zones, which had a similar amount. The same trend and statistical
significances were maintained by normalizing the amount of GAG
per zone when the structural properties were taken into consider-ation (Supporting Information, Fig. S1). The cell number was the
highest in the 500 lm part, which displayed 87564 ± 16218 with
respect to the 700 lm and 900/1100 lm with 57708 ± 7470 and
44970 ± 7955, respectively. To further prove our hypothesis that
protein gradient formation could be correlated to differential
hypoxic conditions due to different cell nutrient availability in
the different scaffold regions, we also analyzed the production of
hypoxia inducible factors (HIF). Our results confirmed that in the
smallest pore size region a higher HIF-1a and HIF-2a secretion
was measured. Both HIFs production decreased with increasing
pore size (Supporting Information, Fig. S3).4. Discussion
In the present study, scaffolds with a discrete gradient in pore
size were fabricated and showed to influence hMSCs chondrogenic
differentiation. The pores increased in size along the longitudinal
axis by increasing the fiber spacing by 200 lm every millimeter.
As expected this led to an increase in porosity and pore volume.
Table 2
Table depicting the structural properties of the entire scaffolds (a) and of the different zones of the gradient scaffolds (b). All the scaffold properties of the gradient scaffolds, with




Objective volume (mm3) 14.06 ± 2.79 15.47 ± 0.01 10.75 ± 0.98
Available surface (mm2) 292.91 ± 16.57 366.82 ± 1.94 198.57 ± 19.42
Porosity (%) 69.52 ± 0.31 70.80 ± 0.06 78.88 ± 0.70
Structure thickness (lm) 218.42 ± 1.64 164.04 ± 0.39 235.54 ± 2.75
Average pore size (lm) 464 ± 14.7 303.5 ± 0.7 650.3 ± 55.1
b Gradient Fiber spacing Pore size (lm) Porosity (%) Available surface (mm2) Total pore volume
(mm3)
1100 538.3 ± 50.6 81.8 ± 0.8 44.7 ± 14.2 8.1 ± 0.4
900 509 ± 4.36 76.0 ± 0.7 59.8 ± 7.6 7.2 ± 0.2
700 389.3 ± 4.9 69.6 ± 1.5 73.6 ± 6.0 6.6 ± 0.1
500 237.7 ± 7.8 55.1 ± 1.4 114.7 ± 11.3 5.5 ± 0.3
Fig. 2. Graphs displaying the cell seeding efficiency of each construct after 8 h (a) and the cell number per construct after 28 days of culture under basic and chondrogenic
conditions (b).
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ent scaffolds where the continuous change of the contact points
between subsequent layers may have contributed to a different
plastic deformation of the molten polymer during extrusion, the
fabricated scaffolds displayed a controlled tunable pore network
architecture. A further improvement on such fluctuations could
be obtained, for example, by better controlling the heating path
of the molten polymer from the cartridge where it is placed to
the needle where it is extruded. Limiting the time window in
which the polymer is heated would result in less thermal degrada-
tion, which would consequently result in less variations due to
change of molten viscosity of the material. Other additive manu-
facturing technologies have been also used to create gradients in
pore size, such as stereolithography [31]. In this respect, the tech-
nology that we have used is not necessarily better than other addi-
tive manufacturing technologies. The novelty of our study lies in
the design of the pore size gradients specifically tuned for stem cell
driven articular cartilage regeneration, while other studies using
additive manufactured scaffolds focused only on improvement ofcell entrapment or better cartilage regeneration with primary dif-
ferentiated chondrocytes.
We expected that the gradient along the z axis should have gen-
erated a sieve effect increasing cell adhesion due to an increased
number of fiber connections. Sobral et al. [15] showed how a gra-
dient structure can enhance the cell entrapment ability of a scaf-
fold by increasing the fiber connections point where cell
adhesion begins. Our findings are in contrast to this study, since
no differences could be seen in cell number after 8 h. Even though
a sieve effect could be expected in our scaffolds, this did not affect
the cell seeding with respect to the control scaffolds. Furthermore,
to compensate as much as possible the effect of gravity on cell
seeding distribution, scaffolds were flipped every day, which is
known to improve cell homogeneous distribution in additive man-
ufactured scaffolds [32]. The different gradient direction of the fore
mentioned study and the consequent number of fibers encoun-
tered along the z axis by the cells could have determined a sieve
effect greater than the one showed by our scaffolds. As expected,
by culturing the scaffolds in basic and chondrogenic medium
Fig. 3. Chondrogenic differentiation at genic level after 14 days (a) and in GAG deposited after 28 days (b) by hMSCs residing in G and NG scaffolds. The expression in
chondrogenic markers did not show any statistical difference among the scaffolds. Small pores and the gradient displayed a beneficial effect on chondrogenic differentiation
with respect to bigger pores. As expected the culture under chondrogenic conditions significantly enhanced the GAG/DNA amount with respect to the culture in basic media.
*Statistical significance p < 0.05 and ***p < 0.001.
Fig. 4. SEM micrograph displaying the ECM deposition of hMSCs cultured under basic (a–f) and chondrogenic medium (g–l) after 28 days. Under chondrogenic conditions,
gradient scaffolds (h, k) displayed an increased amount of deposited ECM compared to NG 500 (g, j) and NG 1100 (i, l) under the same conditions. Scaffolds cultured under
basic medium displayed a very low amount of ECM without major differences among the constructs. Scale bar: 1 mm (a–c, g–i) and 500 lm (d–f, j–l). In the lower part of the
figure (m–p) micrographs displaying the ECM organization of the entire G scaffold cultured under chondrogenic conditions and SEM pictures taken at higher magnifications
of the gradient zones. Scale bar: 1 mm (m) and 500 lm (n–p).
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measured. Cell adhesion on the scaffolds is mediated by proteins
such as laminin, fibronectin and vitronectin [33–35], which are
commonly present in the FBS contained in the basic medium. As
chondrogenic medium does not contain FBS, it is reasonable to
expect a decrease in cell number with culturing time, which is also
in line with the low cell density of articular cartilage tissue.The scaffold features in terms of porosity and pore size did not
affect hMSCs proliferation either. It is known that structural prop-
erties such as pore shape and size affect ECM deposition [16,36]. In
particular, from the study of Woodfield et al., when cells are cul-
tured within structures with small pores, the release of GAG is sig-
nificantly enhanced with respect to structures presenting bigger
pores [16]. Similarly, in our study the scaffolds presenting a
Fig. 5. Differentiation of hMSCs residing in the different compartments of the
gradient scaffolds at a genetic level. The smaller pores seemed to trigger a higher
expression of chondrogenic markers. All the differences between the zones were
statistically significant for all the genes. Aggrecan variation was significant also
between the 700 lm and 900/1100 lm fiber spacing regions. **Statistical signifi-
cance p < 0.01, ***p < 0.001.
Fig. 6. GAG/DNA (a) and cell number (b) in the different compartment of the
gradient scaffolds. Under chondrogenic conditions both the GAG/DNA and the cell
number showed a decreasing trend from the zone with smaller pores to the zone
with bigger pores. Under basic conditions no trend can be seen, the cell number was
higher at the bottom and top part of the scaffolds, whereas GAG/DNA was lower in
the portion with bigger pores. *Statistical significance p < 0.05, **P < 0.01 and
***P < 0.001.
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higher amount of GAG/DNA with respect to the NG1100 scaffolds
(Fig. 3b). The gradient scaffolds supported an amount of GAG/
DNA which is closer to the amount presented by the scaffolds with
a homogenous pore size of 326 lm ± 17 lm and significantly
higher than the amount present in the scaffolds with a homoge-
nous pore size of 968 lm ± 25 lm.
In vivo, chondrogenesis begins from the condensation of hMSCs
after the exposure to TGF-b, which leads to the expression of mole-
cules involved in the condensation process such as tenascin C,
fibronectin and N-cadherin [37,38]. Condensation leads to the
expression of the transcription factor sex determining region Y-
box 9 (sox-9). The cells within the aggregates proceed to chondrob-
lasts and begin to produce aggrecan and collagen type II, IX, and XI.
This development is carried on by the effect of sox-9 in combina-
tion with the influence of a growth factor cocktail, including among
others insulin growth factor-1, fibroblast growth factor-2, and
bone morphogenetic proteins (BMPs)-2, -4, -7, and -14
[37,39,40]. A study of Steinert et al. [41] showed a correlation
between the size of cell aggregate, number of cells and GAG depos-
ited. By increasing the size of the cell aggregate, the cell number
and the GAG deposited also increased. In the present study, we
hypothesized that the structural properties of the construct could
have determined a faster filling of the smaller pores and the conse-
quent aggregate-like state of hMSCs. This may have led to a faster
and more pronounced differentiation toward the chondrogenic lin-
eage. In the full scaffolds, the pore geometry seemed to affect only
the ECM deposition and not the differentiation, since no major dif-
ferences could be seen in terms of chondrogenic markers at the
genic level. The ECM produced seemed to be mainly based on pro-
teoglycans, since the synthesis of coll II mRNA was not significantly
induced, whereas ACAN gene expression was enhanced in all the
constructs already after 2 weeks.
A similar explanation can be proposed for the behavior of
hMSCs residing in the different gradient compartments. The por-
tion with a fiber spacing of 500 lm is the one presenting the small-
est pore size and the highest cell number. It is known that the
initial cell density can drive the differentiation of the hMSCs
[42,43]. The highest cell density per volume unit within the
500 lm part may have led the cells to assume an aggregate likestate, such as the initial mesenchymal cell condensation stage of
the chondrogenic differentiation. N-cadherin mediates cell-cell
interaction during cell condensation. Wnt-7a positively regulates
N-cadherin expression in that stage, and it is regulated by TGF-
beta. TGF-beta is added in the differentiation medium, it activates
p38 MAPK pathway inhibiting the Wnt-7a/beta-catenin-
dependent degradation of Sox9, therefore favoring ECM deposition
and chondrogenesis [44,45]. Bigger pores determined a delay in the
activation of this process, generating a gradient in expression of
chondrogenic markers opposite than the pore size increase. At
the genetic level as well as at the protein level, the same trend
was visible with an over expression of sox9, collagen type II and
aggrecan in the small pore area compared to the 700 lm and the
900/1100 lm fiber spacing zones. In the study by Oh et al. the
chondrogenic differentiation of hMSCs increased by increasing
the pore size. In a PCL scaffolds with a gradient in pore size ranging
from 90 lm to 400 lm, the more favorable environment for chon-
drogenic differentiation was showed by the pore size ranging from
370 to 400 lm after 21 days of culture [46]. Similarly, in the
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played by the zone with pore size of 326 lm ± 17 lm, close to
the optimum presented in the fore mentioned study. A further
increase in pore size depicted an inverted trend with respect to
Oh’s study.
The GAG deposited can be determined just by the higher cell
number in one compartment with respect to another. In order to
decouple the effect of cell number, normalization by DNA was per-
formed. The amount of GAG produced within the gradient zones
can be expressed as total amount of GAG measured in the
500 lm, 700 lm and 900/1100 lm zones. Therefore, normalization
by pore volume unit was also performed. Independently from cell
density and pore volume, the gradient zone with the smallest pore
always resulted with the greater amount of produced GAG. The
increased cell density in the 500 lm zone and the lower pore size
may result in a decreased oxygen tension and nutrient availability.
In literature several papers correlated the oxygen tension and
chondrogenesis [47–49]. Recently, Lee et al. [50] showed the corre-
lation between the survival pathway phosphatidylinositol 3-kinase
(PI3K)/Akt/FoxO pathway, activated by hypoxia, and the increased
chondrogenic differentiation of hMSCs. The low oxygen tension
determines a cytosolic accumulation of hypoxia inducible factor
1 (HIF-1) and its consequent translocation in the nucleus where
it acts as transcription factor. The full underlying mechanism
remains still unclear [50]. Exposure to hypoxic conditions activates
the PI3K/Akt pathway, involved in terminal chondrocyte differenti-
ation, promotes chondrocytes proliferation and inhibits their
hypertrophic differentiation. The enhanced chondrogenic differen-
tiation in the small pore compartment can be based on the gener-
ation of a hypoxic environment due to the cell density and pore
size. This was further supported by the analysis of HIF-1a and
HIF-2a, which both increased with decreasing pore size in our
scaffolds (Supporting Information, Fig. S3).
Articular cartilage presents gradients in cell number, oxygen
and nutrient availability and ECM components which follow differ-
ent directions [1]. In particular, the top part of the scaffolds showed
the highest cell number which is decreasing with the increasing in
pore size. This would suggest the use of the small pores as super-
ficial layer and the 900/1100 lm portion as deep zone. In native
articular cartilage the GAG amount increases when moving from
the deep to the superficial layer. Also the nutrient availability
and oxygen tension decrease from the superficial zone moving to
the deep zone. According to our findings the 500 lm fiber spacing
zone, corresponding to a pore size of 300 lm, is the one showing
the highest expression in chondrogenic markers, in terms of gly-
cosaminoglycans synthesis, as well as HIF secretion. Despite Oh’s
study showed that below 300 lm in pore size chondrogenesis is
not improved, we could not exclude that by further decreasing
the pore size below 300 lm a further increase in chondrogenic dif-
ferentiation could have been observed with our scaffolds as they
display a completely interconnected pore network. Further studies
could look into such smaller pore size, taking into account that
with this technique the pore size limitation is dictated by the fiber
dimension and reaches a resolution limit of approximately
100 lm. Further studies will be aimed at identifying more compo-
nents of the ECM in the different zones. Presence and structure of
collagen type II fibrils can be markers to correlate the structure of
the native cartilage with the one formed within the scaffold. Addi-
tionally, an analysis on the expression of collagen X may clarify if
the state of hypertrophic cartilage is reached and may contribute
deciding which direction to choose for the implantation of the gra-
dient scaffold in an in vivo model. Supplementary studies are still
needed to understand if the hMSCs within a porosity gradient
are able to reach the state of mature cartilage and if the gradients
found in the native cartilage are formed in vivo. A further
application could be the use of such scaffolds for osteochondralregeneration, where the small pores are indeed used for chondro-
genesis, while the larger pores are used for osteogenesis. In this
respect, we have conducted additional studies on the influence of
such gradient scaffolds on the osteogenic differentiation of MSCs
and found out that with increasing pore size osteogenic differenti-
ation was enhanced [51]. Nonetheless, fabricating scaffolds with
structural gradients seems a promising approach to support a hier-
archical chondrogenic differentiation of adult stem cells.
5. Conclusions
Articular cartilage can be seen as a gradient tissue. Therefore,
the use of gradient scaffolds in combination with undifferentiated
cells can be foreseen as tools for its regeneration. In the present
study, a scaffold presenting a gradient in porosity was successfully
produced and the differentiation of hMSCs showed enhanced
chondrogenic gene expression and an increased GAG deposition
with decreasing the pore size, likely due to a related higher cell
density and the consequent generation of hypoxic conditions.
The cells growing within the gradient scaffolds seemed to support
a higher ECM deposition in comparison with the NG scaffolds. The
same trend was observed among the gradient zones. Structural
gradients could, thus, be considered as a promising strategy for
the design of scaffolds aiding to the process of adult stem cell
chondrogenic differentiation.
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